The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 26, 2024

Filed:

May. 10, 2017
Applicants:

Biontech SE, Mainz, DE;

Tron-translationale Onkologie an Der Universitätsmedizin Der Johannesgutenberg-universität Mainz, Mainz, DE;

Inventors:

Mathias Vormehr, Mainz, DE;

Ugur Sahin, Mainz, DE;

Barbara Schrörs, Mainz, DE;

Martin Löwer, Bodenheim, DE;

Sebastian Boegel, Obermoschel, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); A61P 35/04 (2006.01); G01N 33/53 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5035 (2013.01); A61P 35/04 (2018.01); G01N 33/5308 (2013.01); G01N 33/6878 (2013.01); G01N 33/6887 (2013.01); G01N 2333/4712 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention relates to methods for predicting peptides or polypeptides such as T cell epitopes useful for immunotherapy such as for vaccination. In particular, the present invention relates to methods for predicting whether peptides or polypeptides such as tumor-associated antigens or epitopes, in particular tumor-associated neoantigens or neoepitopes, are immunogenic and, in particular, useful for immunotherapy such as for vaccination. The methods of the invention may be used, in particular, for the provision of vaccines which are specific for a patient's tumor and, thus, in the context of personalized cancer vaccines.


Find Patent Forward Citations

Loading…